Biotech | February 10, 2022
Gamida Cell initiates rolling submission of Biologics License Application for Omidubicel
On track to complete the BLA submission in the first half of 2022
On track to complete the BLA submission in the first half of 2022
Potassium chloride is used to prevent or to treat low blood levels of potassium
Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
First of its kind integrated Heart Health Programme on its Health Station ‘hPod’
Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach
New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment
The tele-heath market in India is expected to touch US $ 5.4 billion by 2025 and the adoption of tele-health has accelerated with the onset of Covid-19 in 2020. We caught up with Jeya Kumar, Founder and MD, RaphaCure, a prominent player in this segment and he outlined the opportunities that lie ahead for this segment
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a proprietary brain shuttle, for alpha-synucleinopathies, including Parkinson's disease
After double lung transplantation, he was discharged without supplemental oxygen on the eleventh day
Subscribe To Our Newsletter & Stay Updated
